Plain-English translation of NCT06075485 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying KetoCal®, a specially formulated medical food designed to help children and infants whose epilepsy hasn't responded to anti-seizure medications. Researchers want to understand how well this medication works in real-life settings across France. Your child would follow the special diet as part of their regular medical care, and doctors would track how their seizures respond.
Some children's epilepsy doesn't respond to standard anti-seizure drugs, leaving families with limited treatment options. This study aims to gather real-world evidence about whether the medication can help control seizures in these hard-to-treat cases.
Your child will be admitted to the hospital where doctors will start the special diet during your stay. You'll work with both a doctor and a dietician to learn how to prepare and maintain the diet at home. Your child can receive the medication as a drink (mixed with hot water), added to recipes, or through a feeding tube if needed. The study will follow your child's progress over time to see how well the diet helps control their seizures.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France
Sponsor
Nutricia Nutrition Clinique
Collaborators
Euraxi Pharma
Enrollment target
~133 participants
Started
January 2024
Primary completion
June 2026
Age range
5 Months – 18 Years
Last updated on clinicaltrials.gov in January 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Elmire DEGOUL-COMBESCOT, PhD
Nutricia Nutrition Clinique